Tuberculosis, Multidrug-Resistant (MDR-TB)
1 clinical trials · Condition
◉ Watch Tuberculosis, Multidrug-Resistant (MDR-TB)
| Record | Firm | Date |
|---|---|---|
| A Phase III Study of Oral Sudapyridine (WX-081) Tablets in Rifampicin-Resistant Pulmonary Tuberculosis Patients (NCT05824871) | Shanghai Jiatan Pharmatech Co., Ltd | 2022-09-02 |
Track Tuberculosis, Multidrug-Resistant (MDR-TB) automatically
Every clearance here is in the API, with alerts when new ones post.